title: Infliximab therapy for aggressive mooren ulceration.
authors.forename: Valerie P J
authors.initials: VP
authors.lastname: Saw
authors.forename: Neil
authors.initials: N
authors.lastname: Cornelius
authors.forename: Alan D
authors.initials: AD
authors.lastname: Salama
authors.forename: Charles
authors.initials: C
authors.lastname: Pusey
authors.forename: Susan L
authors.initials: SL
authors.lastname: Lightman
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000188:drug therapy*; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy*; D016572:Cyclosporine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D008297:Male; D009883:Ophthalmic Solutions / Q000008:administration & dosage / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014792:Visual Acuity
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D009883:Ophthalmic Solutions; D014409:Tumor Necrosis Factor-alpha; D016572:Cyclosporine; D000069285:Infliximab